Full text is available at the source.
Abstract
GLP-1 receptor agonists are increasingly used for weight loss management in obese patients.
- GLP-1 receptor agonists are primarily known for their role in glycemic control among diabetic patients.
- There is emerging interest in the perioperative implications of GLP-1 receptor agonists for total joint arthroplasty (TJA) patients.
- The review addresses complications and adverse effects associated with GLP-1 receptor agonist use.
- Considerations for anesthesiologists and TJA surgeons regarding GLP-1 receptor agonists are discussed.
- Clinical practice recommendations for GLP-1 receptor agonist use in 2025 are highlighted.
Simplified